Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.

被引：0
|
作者：
Zang, Mengya
Li, Qi
Hu, Xiaoyun
Yuan, Guosheng
Li, Rong
Guo, Yabing
Chen, Jinzhang
机构：
[1] Southern Med Univ, Hepatol Unit, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16166
引用
收藏
页码：E16166 / E16166
页数：1
相关论文
共 50 条
  • [41] Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread
    Lyu, Ning
    Kong, Yanan
    Pan, Tao
    Mu, Luwen
    Li, Shaolong
    Liu, Yaru
    Deng, Haijing
    Li, Jibin
    Shi, Ming
    Xu, Li
    Guo, Rongping
    Chen, Minshan
    Wu, Peihong
    Zhao, Ming
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (03) : 349 - 357
  • [42] Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
    He, MinKe
    Li, QiJiong
    Zou, RuHai
    Shen, JingXian
    Fang, WanQiang
    Tan, GuoSheng
    Zhou, YuanMin
    Wu, XiaoPing
    Xu, Li
    Wei, Wei
    Le, Yong
    Zhou, ZhongGuo
    Zhao, Ming
    Guo, Ying
    Guo, RongPing
    Chen, MinShan
    Shi, Ming
    JAMA ONCOLOGY, 2019, 5 (07) : 953 - 960
  • [43] Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Zhao, Chang
    Fan, Liwei
    Qi, Feng
    Ou, Shengqiu
    Yu, Lei
    Yi, Xiaoyu
    Ni, Bingqiang
    Zheng, Zhiyong
    Lu, Jianxun
    Zhang, Chengwen
    Cheng, Changsheng
    Lu, Xiong
    Cheng, Lin
    Hu, Tianlian
    Ma, Yilong
    ANTI-CANCER DRUGS, 2016, 27 (07) : 689 - 694
  • [44] Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
    Zhao, Yang
    He, MinKe
    Liang, RunBin
    Li, QiJiong
    Shi, Ming
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 73 - 77
  • [45] S-1 plus oxaliplatin compared with fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy for locally advanced gastric carcinoma.
    Yu, Jiren
    Wu, Yijun
    Gao, Yuan
    Shen, Qianyun
    Zhang, Qing
    Liu, Xiaosun
    Zhu, Kankai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [46] Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma
    Hu, Zili
    Yang, Zhenyun
    Pan, Yangxun
    Fu, Yizhen
    Wang, Jiongliang
    Zhou, Zhongguo
    Chen, Minshan
    Hu, Dandan
    Zhang, Yaojun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study
    Sun, Juxian
    Liu, Chang
    Wang, Nanya
    Jiang, Dafeng
    Zhang, Fan
    Shi, Jie
    Cheng, Shuqun
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1663 - 1670
  • [48] Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study
    Zaanan, Aziz
    Williet, Nicolas
    Hebbar, Mohamed
    Dabakuyo, Tienhan Sandrine
    Fartoux, Laetitia
    Mansourbakht, Touraj
    Dubreuil, Olivier
    Rosmorduc, Olivier
    Cattan, Stephane
    Bonnetain, Franck
    Boige, Valerie
    Taieb, Julien
    JOURNAL OF HEPATOLOGY, 2013, 58 (01) : 81 - 88
  • [49] Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
    Qin, Shukui
    Bai, Yuxian
    Lim, Ho Yeong
    Thongprasert, Sumitra
    Chao, Yee
    Fan, Jia
    Yang, Tsai-Shen
    Bhudhisawasdi, Vajarabhongsa
    Kang, Won Ki
    Zhou, Yu
    Lee, Jee Hyun
    Sun, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (28) : 3501 - +
  • [50] Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials
    Huang, YeXing
    Zhang, LiHong
    He, MinKe
    Lai, ZhiCheng
    Bu, XiaoYun
    Wen, DongSheng
    Li, QiJiong
    Xu, Li
    Wei, Wei
    Zhang, YaoJun
    Zhou, ZhongGuo
    Chen, MinShan
    Guo, RongPing
    Shi, Ming
    Kan, Anna
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
12345